Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

177 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
How I Evaluate a High Anion Gap Metabolic Acidosis.
Azim A, Hu B, Gilligan S, Sarwal A, Hartsell S, Pandya V, Raphael KL. Azim A, et al. Among authors: sarwal a. Clin J Am Soc Nephrol. 2024 Apr 1;19(4):525-527. doi: 10.2215/CJN.0000000000000381. Epub 2023 Nov 17. Clin J Am Soc Nephrol. 2024. PMID: 37976122 No abstract available.
The Sit Less, Interact and Move More (SLIMM-2) Trial: Protocol for a randomized control trial of a sedentary behavior intervention, resistance training and semaglutide on sedentary behavior in persons with chronic kidney disease.
Christensen JC, Anand S, Chertow GM, Lyden K, Sarwal A, Bjordahl T, Boucher R, Mohammed A, Oro EG, Akramimoghaddam F, Katkam N, Takyi A, Bissada G, Chakravartula AR, Lee E, Zheng A, Wei G, Greene T, Beddhu S. Christensen JC, et al. Among authors: sarwal a. Contemp Clin Trials. 2024 Nov 26:107766. doi: 10.1016/j.cct.2024.107766. Online ahead of print. Contemp Clin Trials. 2024. PMID: 39608749
Intravenous glibenclamide for cerebral oedema after large hemispheric stroke (CHARM): a phase 3, double-blind, placebo-controlled, randomised trial.
Sheth KN, Albers GW, Saver JL, Campbell BCV, Molyneaux BJ, Hinson HE, Cordonnier C, Steiner T, Toyoda K, Wintermark M, Littauer R, Collins J, Lucas N, Nogueira RG, Simard JM, Wald M, Dawson K, Kimberly WT; CHARM Trial investigators. Sheth KN, et al. Lancet Neurol. 2024 Dec;23(12):1205-1213. doi: 10.1016/S1474-4422(24)00425-3. Lancet Neurol. 2024. PMID: 39577921 Clinical Trial.
Correction: Common Data Elements for Disorders of Consciousness: Recommendations from the Working Group on Goals-of-Care and Family/Surrogate Decision-Maker Data.
Jaffa MN, Kirsch HL, Creutzfeldt CJ, Guanci M, Hwang DY, LeTavec D, Mahanes D, Natarajan G, Steinberg A, Zahuranec DB, Muehlschlegel S; Curing Coma Campaign Collaborators. Jaffa MN, et al. Neurocrit Care. 2024 Oct 15. doi: 10.1007/s12028-024-02098-9. Online ahead of print. Neurocrit Care. 2024. PMID: 39407076 No abstract available.
Correction: Common Data Elements for Disorders of Consciousness: Recommendations from the Working Group on Neuroimaging.
Edlow BL, Boerwinkle VL, Annen J, Boly M, Gosseries O, Laureys S, Mukherjee P, Puybasset L, Stevens RD, Threlkeld ZD, Newcombe VFJ, Fernandez-Espejo D; Curing Coma Campaign and its Contributing Members. Edlow BL, et al. Neurocrit Care. 2024 Oct 11. doi: 10.1007/s12028-024-02101-3. Online ahead of print. Neurocrit Care. 2024. PMID: 39394544 No abstract available.
177 results